MamStartup: Bioceltix is a biotech startup that does business in the veterinary industry – the company focuses on developing stem-cell-based biopharmaceuticals.
These biopharmaceuticals are a safer as well as more effective alternative to synthetic drugs, which treat only symptoms, not underlying causes. The aforementioned „synthetics” still remain by far the most popular choice when it comes to treating inflammation.
This exciting company is also among the finalist of the forth edition of Chivas Ventures – a contest created specifically to recognise the most socially-involved startups. Łukasz Bzdzion, CEO of Bioceltix, talked about the details surrounding the projects. If you want to know about the various stages of development, biggest challenges and when the product will actually become available to the market – read the full interview below.